Cargando…
2例免疫检查点抑制剂联合化疗引发2型糖尿病个案报道
Immune checkpoint inhibitors (ICIs) have become an important means of cancer treatment, and their application in the clinic is becoming more and more widespread. The adverse reactions caused by ICIs are gradually recognized. Among them, immunotherapy-related diabetes is a rare adverse reaction and t...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051303/ https://www.ncbi.nlm.nih.gov/pubmed/35477193 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.10 |
Ejemplares similares
-
免疫检查点抑制剂相关糖尿病2例报道及文献回顾
Publicado: (2022) -
经3种ALK抑制剂及化疗治疗的1例非小细胞肺癌病例报道
Publicado: (2021) -
PD-1单抗导致免疫检查点抑制剂相关肺炎1例——吡非尼酮治疗的安全性和有效性
Publicado: (2021) -
1例3次挑战培美曲塞方案治疗晚期非小细胞肺癌有效的个案报道
Publicado: (2019) -
肺癌免疫检查点抑制剂的联合治疗研究进展
Publicado: (2020)